David Stout
Director/Board Member at JABIL INC.
Net worth: 9 M $ as of 2024-03-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jean-Paul Clozel | M | 69 | 25 years | |
| Mark Mondello | M | 60 | 32 years | |
| Joshua Schafer | M | 53 | 4 years | |
| Andrew C. Weiss | M | 55 | 10 years | |
| Martine Clozel | M | 68 | 27 years | |
| Abraham Noah Oler | M | 48 |
Allos Therapeutics, Inc.
 Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO. | 12 years |
| Timothy Traud | M | - | 23 years | |
| Robert Katz | M | 62 | 8 years | |
| Chad D. Costley | M | - |
BlueWillow Biologics, Inc.
 BlueWillow Biologics, Inc. BiotechnologyHealth Technology BlueWillow Biologics, Inc. develops biopharmaceutical products. It offers vaccines targeting respiratory, sexually transmitted, and intranasal immunotherapy for food and respiratory allergies. The company was founded by James R. Baker Jr. and is headquartered in Ann Arbor, MI. | - |
| Kathleen Walters | F | 72 | 12 years | |
| Michael Dastoor Dastoor | M | 59 | 24 years | |
| Alexander Khatuntsev | M | 45 | 17 years | |
| Kelly P. Justice | M | - | 13 years | |
| Adam Berry | M | - | 14 years | |
| Pamela J. Claypool | F | - | 17 years | |
| André Muller | M | 60 | 11 years | |
| Bimal Shah | M | 48 |
Allos Therapeutics, Inc.
Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO. | 12 years |
| Jamie Siminoff | M | 47 | - | |
| Tiger Tyagarajan | M | 62 | - | |
| Anousheh Ansari | F | 58 | 8 years | |
| Gary E. Costley | M | 80 |
BlueWillow Biologics, Inc.
BlueWillow Biologics, Inc. BiotechnologyHealth Technology BlueWillow Biologics, Inc. develops biopharmaceutical products. It offers vaccines targeting respiratory, sexually transmitted, and intranasal immunotherapy for food and respiratory allergies. The company was founded by James R. Baker Jr. and is headquartered in Ann Arbor, MI. | - |
| John Plant | M | 70 | 8 years | |
| Christopher Holland | M | 58 | 6 years | |
| George G. Arida | M | - |
BlueWillow Biologics, Inc.
BlueWillow Biologics, Inc. BiotechnologyHealth Technology BlueWillow Biologics, Inc. develops biopharmaceutical products. It offers vaccines targeting respiratory, sexually transmitted, and intranasal immunotherapy for food and respiratory allergies. The company was founded by James R. Baker Jr. and is headquartered in Ann Arbor, MI. | 5 years |
| Steven Raymund | M | 69 | 28 years | |
| Kevin M. McBride | M | - | 8 years | |
| Susanne Dorn | F | - | 6 years | |
| Rajesh Shrotriya | M | 79 |
Allos Therapeutics, Inc.
Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO. | 12 years |
| Daryn Smith | M | 54 | 22 years | |
| Roger D’Orazio | M | - |
BlueWillow Biologics, Inc.
BlueWillow Biologics, Inc. BiotechnologyHealth Technology BlueWillow Biologics, Inc. develops biopharmaceutical products. It offers vaccines targeting respiratory, sexually transmitted, and intranasal immunotherapy for food and respiratory allergies. The company was founded by James R. Baker Jr. and is headquartered in Ann Arbor, MI. | - |
| Fred McCoy | M | - | 2 years | |
| May Yap | M | 54 | 10 years | |
| Gerald Creadon | M | 50 | 29 years | |
| Frank McKay | M | 54 | 5 years | |
| Kristine Melachrino | F | 46 | 17 years | |
| Gary Schick | M | - | 6 years | |
| Luigi Lenaz | M | 83 |
Allos Therapeutics, Inc.
Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO. | 12 years |
| Jerome Pelletan | M | 54 | 8 years | |
| Edwin Robertson | M | - | 17 years | |
| François Darchis | M | 68 | 8 years | |
| James E. Cook | M | - | 11 years | |
| Terry L. Lodge | M | 67 | 19 years | |
| Ronald J. Stark | M | 60 | 21 years | |
| Roberto Ferri | M | 59 | - | |
| Pierre Dufour | M | 68 | 8 years | |
| Michael E. Schick | M | 57 |
Allos Therapeutics, Inc.
Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO. | 15 years |
| W. Wilmington | M | 64 |
BlueWillow Biologics, Inc.
BlueWillow Biologics, Inc. BiotechnologyHealth Technology BlueWillow Biologics, Inc. develops biopharmaceutical products. It offers vaccines targeting respiratory, sexually transmitted, and intranasal immunotherapy for food and respiratory allergies. The company was founded by James R. Baker Jr. and is headquartered in Ann Arbor, MI. | - |
| Steve Hope | M | - | 15 years | |
| Jack Appolonia | M | - | 22 years | |
| Susan Wagner-Fleming | F | - | 7 years | |
| Timur Aydin | M | - | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Forbes Ian James Alexander | M | 64 | 25 years | |
| Stephen J. Hoffman | M | 70 |
Allos Therapeutics, Inc.
Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO. | 18 years |
| William Burns | M | 76 |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | 8 years |
| Graham Hetherington | M | 65 | 6 years | |
| Timothy Main | M | 66 | 34 years | |
| Daniel Cohen | M | - | 13 years | |
| Jean Pierre Malo | M | 69 | 13 years | |
| Michael Jacobi | M | 71 | 8 years | |
| Paul Berns | M | 57 |
Allos Therapeutics, Inc.
Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO. | 6 years |
| Angus Russell | M | 68 | 14 years | |
| John C. van Roden | M | 74 | 10 years | |
| Richard C. Ill | M | 80 | 10 years | |
| Hendrica Verhagen | F | 57 | 2 years | |
| Thomas Sansone | M | 74 | 41 years | |
| Jean-Pierre Garnier | M | 75 | 10 years | |
| Raul Cesan | M | 76 |
Schering Laboratories Advertising, Inc.
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | 9 years |
| James Bowling | M | 56 | 10 years | |
| Scott Applebaum | M | 57 | 2 years | |
| Kenneth Wilson | M | 59 | 24 years | |
| William Peters | M | 60 | 28 years | |
| Susan Kilsby | F | 65 | 8 years | |
| Mitchell Glass | M | - |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | 1 years |
| Richard L. Bevan | M | - |
Smithkline Beecham Plc
 Smithkline Beecham Plc Pharmaceuticals: OtherHealth Technology Smithkline Beecham Plc develops and manufactures pharmaceutical products. The company markets pharmaceuticals for human and animal healthcare consumption, vaccines, over the counter medicines, health related consumer products, clinical laboratory testing services, disease management and pharmaceutical benefit management. It is headquartered in Brentford, UK. | 16 years |
| David R. Ginsburg | M | 71 | 8 years | |
| David Solomon | M | 63 | 2 years | |
| Howard Mayer | M | 62 |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | 6 years |
| Mark McHale | M | 59 |
Smithkline Beecham Plc
Smithkline Beecham Plc Pharmaceuticals: OtherHealth Technology Smithkline Beecham Plc develops and manufactures pharmaceutical products. The company markets pharmaceuticals for human and animal healthcare consumption, vaccines, over the counter medicines, health related consumer products, clinical laboratory testing services, disease management and pharmaceutical benefit management. It is headquartered in Brentford, UK.
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | 6 years |
| Flemming Ørnskov | M | 66 | 6 years | |
| Robert Harrell | M | - |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | 8 years |
| Anne Minto | F | 70 | 8 years | |
| Dominic Blakemore | M | 54 | 4 years | |
| William D. Morean | M | 68 | 36 years | |
| Lee Muller Thomas | M | 79 | 18 years | |
| Frank Newman | M | 75 | 20 years | |
| Lawrence J. Murphy | M | 81 | 27 years | |
| Steven Gillis | M | 71 | 7 years | |
| Philippe Chambon | M | 65 | - | |
| Timothy Patrick Lynch | M | 54 |
Allos Therapeutics, Inc.
Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO. | 6 years |
| Robert Alexander Ingram | M | 81 |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | 9 years |
| Jeffrey Leiden | M | 68 |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | 6 years |
| Richard Kogan | M | 81 |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | 21 years |
| Hugh A. D'Andrade | M | 85 |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | 4 years |
| Daniel E. Greenleaf | M | 59 |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | 10 years |
| Marc H. Graboyes | M | 54 |
Allos Therapeutics, Inc.
Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO. | 8 years |
| Matthew Emmens | M | 72 | 11 years | |
| Dean A. Bertolino | M | 55 | - | |
| Beth A. Walters | F | - | 27 years | |
| Katharine Knobil | M | 60 |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | 21 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 73 | 73.74% |
| Ireland | 13 | 13.13% |
| Switzerland | 9 | 9.09% |
| France | 5 | 5.05% |
| United Kingdom | 2 | 2.02% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- David Stout
- Personal Network
